These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37637068)

  • 61. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
    Aziz M; Akhtar S; Malik A
    Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-edged sword: The world according to Capicua in cancer.
    Tanaka M; Yoshimoto T; Nakamura T
    Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Advances into Understanding the Vital Role of the Mitochondrial Citrate Carrier (CIC) in Metabolic Diseases.
    Peng R; Zhang M; Wang H; Lin J; Wang H; Wang F; Liu L; Zhao Q; Liu J
    Pharmacol Res; 2020 Nov; 161():105132. PubMed ID: 32814170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma.
    Zhang L; Giuste F; Vizcarra JC; Li X; Gutman D
    Front Oncol; 2020; 10():937. PubMed ID: 32676453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
    Choi N; Park J; Lee JS; Yoe J; Park GY; Kim E; Jeon H; Cho YM; Roh TY; Lee Y
    Oncotarget; 2015 Sep; 6(27):23533-47. PubMed ID: 26124181
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors.
    Chan AK; Pang JC; Chung NY; Li KK; Poon WS; Chan DT; Shi Z; Chen L; Zhou L; Ng HK
    Mod Pathol; 2014 Mar; 27(3):332-42. PubMed ID: 24030748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune responses to human cancer stem-like cells/cancer-initiating cells.
    Hirohashi Y; Torigoe T; Tsukahara T; Kanaseki T; Kochin V; Sato N
    Cancer Sci; 2016 Jan; 107(1):12-7. PubMed ID: 26440127
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion.
    Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
    Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.
    Serrano M; Morán L; Martinez-Flores JA; Mancebo E; Pleguezuelo D; Cabrera-Marante O; Delgado J; Serrano A
    Front Immunol; 2019; 10():2891. PubMed ID: 31921152
    [No Abstract]   [Full Text] [Related]  

  • 72. A Rare Case of Round Cell Sarcoma with CIC-DUX4 Mutation Mimicking a Phlegmon: Review of Literature.
    Donthi D; Malik P; Prenshaw KL; Hong H
    Am J Case Rep; 2020 Sep; 21():e925683. PubMed ID: 32873768
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
    Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
    Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The CAM Model for
    Komatsu A; Matsumoto K; Yoshimatsu Y; Sin Y; Kubota A; Saito T; Mizumoto A; Ohashi S; Muto M; Noguchi R; Kondo T; Tamanoi F
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.
    Romaguera-Ros M; Peris-Celda M; Oliver-De La Cruz J; Carrión-Navarro J; Pérez-García A; García-Verdugo JM; Ayuso-Sacido A
    Stem Cell Rev Rep; 2012 Mar; 8(1):288-98. PubMed ID: 21717133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Success rates of patients with poor emptying on clean intermittent catheterization.
    Di Pierdomenico AA; Radomski SB
    Can J Urol; 2014 Apr; 21(2):7188-93. PubMed ID: 24775569
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Origins of context-dependent gene repression by capicua.
    Forés M; Ajuria L; Samper N; Astigarraga S; Nieva C; Grossman R; González-Crespo S; Paroush Z; Jiménez G
    PLoS Genet; 2015 Jan; 11(1):e1004902. PubMed ID: 25569482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.